Ignacio
Gil Bazo
Forscher bis um 2022
Miguel
Fernández de Sanmamed Gutiérrez
Consultor Médico
Publikationen, an denen er mitarbeitet Miguel Fernández de Sanmamed Gutiérrez (5)
2020
-
Are Immune Checkpoint Inhibitors Effective Against Uncommon Oncogene-Driven NSCLC Subtypes?
Journal of Thoracic Oncology
-
PD-1/PD-L1 Blockers in NSCLC Brain Metastases: Challenging Paradigms and Clinical Practice
Clinical Cancer Research, Vol. 26, Núm. 16, pp. 4186-4197
-
Short-term starvation reduces IGF-1 levels to sensitize lung tumors to PD-1 immune checkpoint blockade
Nature cancer, Vol. 1, Núm. 1, pp. 75-85
2018
-
Combined immunotherapy encompassing intratumoral poly-ICLC, dendritic-cell vaccination and radiotherapy in advanced cancer patients
Annals of Oncology, Vol. 29, Núm. 5, pp. 1312-1319
-
Genomic characterization of individuals presenting extreme phenotypes of high and low risk to develop tobacco-induced lung cancer
Cancer Medicine, Vol. 7, Núm. 7, pp. 3474-3483